Tag: obesity

Browse all articles tagged with “obesity”.

3 articles

Retatrutide: The Triple Agonist Setting New Records in Obesity Research

A research-focused overview of retatrutide (LY3437943), the investigational triple GIP/GLP-1/glucagon receptor agonist from Eli Lilly that achieved 23.7% body weight reduction in Phase 2 trials, the largest ever recorded in an obesity trial.

2026-03-06·15 min read

Retatrutidetriple agonistGIPGLP-1glucagonobesitymetabolic healthEli Lilly

Metabolic Health

Mazdutide: The Dual GLP-1/Glucagon Agonist From Innovent Biologics

A research overview of mazdutide (IBI362), the dual GLP-1/glucagon receptor agonist developed by Innovent Biologics for the Chinese and global markets, with Phase 3 data showing significant weight loss and metabolic improvements.

2026-01-20·9 min read

MazdutideGLP-1glucagondual agonistInnovent Biologicsobesitymetabolic healthChina

Metabolic Health

Adipotide (FTPP): The Fat Vasculature-Targeting Peptide With Primate Data and Safety Concerns

A detailed research overview of adipotide (FTPP/prohibitin-targeting peptide), the chimeric peptide that targets white fat tissue vasculature for apoptosis, examining its dramatic primate weight loss data alongside significant safety and toxicity concerns.

2026-01-10·14 min read

AdipotideFTPPprohibitinfat lossvasculature targetingobesityprimate studies

←Back to blog

For informational purposes only. Not medical advice. Always consult with qualified healthcare professionals.